{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":2,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":33,"n_cols":5,"rows_kept":33,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[2,4,2,5],[3,2,3,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[9,2,9,3],[10,2,10,3],[11,2,11,3],[13,2,13,3],[13,4,13,5],[14,2,14,3],[14,4,14,5],[15,2,15,3],[17,2,17,3],[19,2,19,3],[20,2,20,3],[21,2,21,3],[25,2,25,3],[26,2,26,3],[30,2,30,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA990001107840403321"]
[null,null,"Autore",null,"Van Cleve, J."]
[null,null,"Titolo",null,"The Philosophy of Right and Left : Incongruent Counterparts and the Nature of Space / edited by James Van Cleve, Robert E. Frederick"]
[null,null,"Pubbl/distr/stampa",null,"Dordrecht [etc.] : Kluwer, 1991"]
[null,null,"ISBN",null,"0-7923-0844-1"]
[null,null,"Descrizione fisica",null,"x, 370 p. ; 23 cm"]
[null,null,"Collana",null,"The University of Western Ontario Series in Philosophy of Science ; vol. 46"]
[null,null,"Disciplina",null,"530"]
[null,null,"Locazione",null,"FI1"]
[null,null,"Collocazione",null,"4B-161"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,"2.","Record Nr.",null,"UNINA9910826891403321"]
[null,null,"Titolo",null,"Maximizing the impact of the Cures Acceleration Network : accelerating the development of new drugs and diagnostics : workshop summary / / Steve Olson and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies"]
[null,null,"Pubbl/distr/stampa",null,"Washington, District of Columbia : , : National Academies Press, , [2012]"]
[{"$nulls":4},"©2012"]
[null,null,"ISBN",null,"0-309-26119-8"]
[{"$nulls":4},"0-309-26117-1"]
[null,null,"Descrizione fisica",null,"1 online resource (132 p.)"]
[null,null,"Disciplina",null,"615.1/9"]
[null,null,"Soggetti",null,"Drug monitoring"]
[{"$nulls":4},"Drug development - United States"]
[{"$nulls":4},"Drugs - United States - Design"]
[{"$nulls":4},"Pharmaceutical industry - United States - Quality control"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references (pages 71)."]
[null,null,"Nota di contenuto",null,"Introduction [The history and goals of CAN (Cures Acceleration Network)] -- Approaches to accelerating translational science -- Application of matching authority -- Application of flexible research authority -- Situating CAN within the drug development ecosystem -- Final reflections on ways to maximize the goals of CAN."]
[null,null,null,"Sommario/riassunto","Advances in technologies and knowledge are creating new avenues for research and opportunities for the discovery and clinical development of innovative therapies and diagnostics. However, despite these opportunities, only a small fraction of investigational products are successfully developed into cures and therapies that can be accessed by patients. One response to the ever-widening gap between the number and promise of basic scientific discoveries and the translation of those discoveries into therapies is a renewed emphasis on collaborative approaches among federal agencies, academia, and industry, all directed at the advancement of the drug development enterprise. The newly developed Cures Acceleration Network (CAN)-a part of the National Center for Advancing Translational Sciences "]
[{"$nulls":4},"(NCATS) within the National Institutes of Health (NIH)-has the potential to catalyze widespread changes in NCATS, NIH, and the drug development ecosystem in general. On June 4-5, 2012, the IOM Forum on Drug Discovery, Development, and Translation held, at the request of NCATS, a workshop-bringing together members of federal government agencies, the private sector, academia, and advocacy groups-to explore options and opportunities in the implementation of CAN. Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary summarizes the workshop.\"--Publisher's description."]